İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 65
YÖKSİS65 OpenAlex0
Proje 2
Kitap 10
Bildiri 42

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 54
h-indeks 8 Türkiye yüzdelik dilimi: 78 Üniversitesinde h-indekse göre 853. / 2.315
i10-indeks
7
Toplam atıf
256
Türkiye’de üst %20
Makale başına
4,7
FWCI
0,88
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
4

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 49
  • Q1 19 %38,8
  • Q2 13 %26,5
  • Q3 14 %28,6
  • Q4 3 %6,1
WoS (JCR) 56
  • Q1 15 %26,8
  • Q2 13 %23,2
  • Q3 9 %16,1
  • Q4 19 %33,9
TR Index 26 makale
OpenAlex atıf yüzdelik
Üst %10
Üst %106
Ort. · n 57 %53,6
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 53

WoS (JCR)

  • YÖKSİS satırı 60

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

65makale

Yayını olan dergiler

36 dergi

Daralt

Scopus (SJR)
WoS (JCR)
TR Index

Makale listesi

  1. 2026 Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis Indian Journal of Hematology and Blood Transfusion DOI 10.1007/s12288-025-02107-7 2 YÖKSİS kaydı YÖKSİS SJR Q3 JCR Q4 OpenAlex 17.8%
  2. 2025 Impact of pharmacist-led interventions on economic, clinical, and humanistic outcomes (ECHO) in patients admitted to emergency departments: A systematic review of randomized controlled trials Research in Social and Administrative Pharmacy DOI 10.1016/j.sapharm.2025.10.007 YÖKSİS SJR Q1 JCR Q1 OpenAlex 33.6%
  3. 2025 Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19 Medical Principles and Practice DOI 10.1159/000543773 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.9%
  4. 2025 In reply to the letter to the editor regarding ‘Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin’ International Journal of Antimicrobial Agents DOI 10.1016/j.ijantimicag.2025.107576 YÖKSİS SJR Q1 JCR Q1
  5. 2025 Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence British Journal of Clinical Pharmacology DOI 10.1002/bcp.70077 YÖKSİS SJR Q1 JCR Q2 OpenAlex 70.6%
  6. 2025 The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units Medical Mycology DOI 10.1093/mmy/myaf002 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.6%
  7. 2025 Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study International Journal of Antimicrobial Agents DOI 10.1016/j.ijantimicag.2025.107446 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.3%
  8. 2025 Therapeutic drug monitoring in patients treated with vancomycin: a single center, prospective, observational, real-world study European Journal of Clinical Microbiology & Infectious Diseases DOI 10.1007/s10096-025-05182-w 2 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.6%
  9. 2025 Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour International Journal of Clinical Pharmacy DOI 10.1007/s11096-025-01868-5 3 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 97.8%
  10. 2025 Hekim ve Eczacıların Farmakovijilans Hakkında Bilgi, Tutum ve Davranışlarının Değerlendirilmesi: Kesitsel Araştırma Literatür Eczacılık Bilimleri Dergisi DOI 10.5336/pharmsci.2024-105678 YÖKSİS
  11. 2025 Stenotrophomonas maltophilia Kaynaklı İnfeksiyonların Tedavisi: Geleneksel Bir Derleme Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi DOI 10.5578/flora.2025011336 YÖKSİS TR Index JCR Q4 OpenAlex 3.8%
  12. 2024 Examination of drug removal profiles in patients undergoing therapeutic plasma exchange: A retrospective study Therapeutic Apheresis and Dialysis DOI 10.1111/1744-9987.14185 YÖKSİS SJR Q3 JCR Q3 OpenAlex 14.6%
  13. 2024 Monitoring of the cerebrospinal fluid voriconazole level in a patient with recurrent Candida meningitis after pituitary surgery International Journal of Antimicrobial Agents DOI 10.1016/j.ijantimicag.2024.107379 YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.4%
  14. 2024 Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia Journal of Investigative Medicine DOI 10.1177/10815589241232366 YÖKSİS SJR Q2 JCR Q2 OpenAlex 63.2%
  15. 2024 Antimicrobial management in patients undergoing therapeutic plasma exchange: A Cross-Sectional Nationwide Survey Journal of Investigative Medicine DOI 10.1177/10815589241270414 YÖKSİS SJR Q2 JCR Q2 OpenAlex 17.4%
  16. 2024 Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis The Journal of Infection in Developing Countries DOI 10.3855/jidc.19290 YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.7%
  17. 2024 Effect of therapeutic plasma exchange on antimicrobials in critically ill patients Critical Care DOI 10.1186/s13054-024-05077-w YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.2%
  18. 2024 Beyond conventional dosing: tailoring antimicrobial regimens for cachexia European Journal of Hospital Pharmacy DOI 10.1136/ejhpharm-2024-004250 YÖKSİS SJR Q2 JCR Q4 OpenAlex 52.9%
  19. 2024 Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study Thrombosis Research DOI 10.1016/j.thromres.2024.03.003 YÖKSİS SJR Q2 JCR Q2 OpenAlex 79.5%
  20. 2024 Evaluation of infectious diseases physicians’ attitudes to dyslipidemia management in PLWH Postgraduate Medicine DOI 10.1080/00325481.2024.2394015 YÖKSİS SJR Q2 JCR Q1 OpenAlex 68.7%

← Akademisyenlere dön